Immune Pharmaceuticals applies a personalized approach to treatment and developing novel antibody therapeutics. Founded by Daniel Teper and Jean Kadouche in 2010, Immune Pharmaceuticals is headquartered in New York.
The Pulse of New York Tech
Join the millions and keep up with the stories shaping entrepreneurship. Sign up today.